Laddar...
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
BACKGROUND: In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable to that of cutaneous mastocytosis (CM). The aim of...
Sparad:
| I publikationen: | Allergy |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7115854/ https://ncbi.nlm.nih.gov/pubmed/32108361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14248 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|